350 Participants Needed

Trauma Resilience and Recovery Program for PTSD

GB
HE
BS
SK
Overseen BySusan Kartiko, MD/PhD
Age: Any Age
Sex: Any
Trial Phase: Academic
Sponsor: Medical University of South Carolina
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

What data supports the effectiveness of the Trauma Resilience and Recovery Program treatment for PTSD?

The Trauma Resilience and Recovery Program (TRRP) has shown high engagement rates in trauma centers, indicating its potential effectiveness in addressing PTSD and depression after traumatic injuries. Additionally, similar programs like the PTSD Recovery Program have been effective in reducing PTSD symptoms in different populations, such as refugees, suggesting that TRRP may also be beneficial.12345

How is the Trauma Resilience and Recovery Program (TRRP) treatment different from other PTSD treatments?

The Trauma Resilience and Recovery Program (TRRP) is unique because it is a technology-enhanced model that combines education, screening, and service referrals to address PTSD and depression after traumatic injury, focusing on high engagement even in resource-limited settings. Unlike traditional cognitive therapies, it uses a 'bottom-up' approach, emphasizing sensory awareness for emotion regulation, which may be more effective for trauma recovery.34567

What is the purpose of this trial?

The purpose of this study to learn about patients' experience with the Trauma Resilience and Recovery program (TRRP) and/or the enhanced care group.

Research Team

KR

Kenneth Ruggiero, PhD

Principal Investigator

Medical University of South Carolina

Eligibility Criteria

This trial is for English or Spanish speakers aged 16+ who are admitted to George Washington University's trauma center and show a risk for PTSD or depression after injury. Exclusions include severe brain injuries, cognitive impairments, psychosis, inability to communicate verbally, or serious substance abuse.

Exclusion Criteria

Patients who have a Glasgow Coma Scale score under 13 at hospital admission
Patients with moderate to severe cognitive impairment (as measured by the Montreal Cognitive Assessment)
I do not have a current, serious substance abuse problem.
See 2 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Initial Intervention

Participants receive education at the bedside about mental health recovery after traumatic injury, risk assessment, and brief intervention for high-risk patients

1-2 weeks
In-person at the trauma center

Symptom Monitoring and Education

Participants engage in symptom self-monitoring and continued education via an automated text messaging system

4 weeks

PTSD and Depression Screening

Screening for PTSD and depression by chatbot or telephone 30 days post-injury

1 week
Virtual

Referral and Handoff

Referral and warm handoff to mental health services if needed

Ongoing as needed

Follow-up

Participants are monitored for clinical and functional outcomes at 3-, 6-, and 12-months post-baseline

12 months
3 visits (in-person or virtual)

Treatment Details

Interventions

  • Trauma Resilience and Recovery Program
Trial Overview The study evaluates the Trauma Resilience and Recovery Program (TRRP) compared with enhanced care in patients at risk of developing PTSD or depression following traumatic injury. It aims to understand patient experiences within these programs.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Trauma Resilience and Recovery ProgramExperimental Treatment1 Intervention
TRRP is a stepped model of care that delivers education at the bedside about mental health recovery after traumatic injury as well as risk assessment and brief intervention for high-risk patients (Step 1), fosters symptom monitoring and continued education (Step 2), screens for PTSD and depression 30 days post-injury (Step 3), and provides a referral and warm handoff to mental health services if needed (Step 4)
Group II: Enhanced Usual Care ConditionActive Control1 Intervention
Patients in the EUC arm will be given education about mental health after traumatic injury, educational materials about mental health recovery, and local referral information to assist treatment-seeking patients in seeking care.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Medical University of South Carolina

Lead Sponsor

Trials
994
Recruited
7,408,000+

George Washington University

Collaborator

Trials
263
Recruited
476,000+

Agency for Healthcare Research and Quality (AHRQ)

Collaborator

Trials
415
Recruited
6,777,000+

Findings from Research

In a study involving 116 PTSD patients, both Brief Eclectic Psychotherapy (BEP) and Eye Movement Desensitization and Reprocessing (EMDR) therapy led to significant increases in posttraumatic growth, indicating that these therapies not only help reduce PTSD symptoms but also promote positive personal development.
The research found that greater reductions in PTSD symptoms were associated with greater increases in posttraumatic growth, suggesting a relationship between symptom improvement and personal growth, although no specific treatment was found to predict these outcomes.
Turning wounds into wisdom: Posttraumatic growth over the course of two types of trauma-focused psychotherapy in patients with PTSD.Nijdam, MJ., van der Meer, CAI., van Zuiden, M., et al.[2018]
The Trauma Recovery Project study, involving 1,048 trauma patients, found that functional limitations persisted significantly at 12 and 18 months post-injury, with mean Quality of Well-Being scores remaining below the healthy norm, indicating a long-term impact on quality of life after major trauma.
Factors such as postinjury depression, PTSD, serious extremity injuries, and the number of days spent in the intensive care unit were identified as significant predictors of poor functional outcomes, highlighting the need for comprehensive post-trauma care.
Outcome after major trauma: 12-month and 18-month follow-up results from the Trauma Recovery Project.Holbrook, TL., Anderson, JP., Sieber, WJ., et al.[2022]
The PTSD Recovery Program, which includes group therapy alongside individual therapy and medication, was effectively used to treat PTSD in 18 refugees over 10 weekly sessions, showing positive outcomes based on pre- and post-intervention questionnaires.
Qualitative data from participants indicated symptom improvement, and providers reported high satisfaction with the program, supporting its efficacy as an adjunctive treatment for PTSD in this population.
Using a Veterans Affairs Posttraumatic Stress Disorder Group Therapy Program With Refugees.Haefner, J., Abedi, M., Morgan, S., et al.[2019]

References

Turning wounds into wisdom: Posttraumatic growth over the course of two types of trauma-focused psychotherapy in patients with PTSD. [2018]
Outcome after major trauma: 12-month and 18-month follow-up results from the Trauma Recovery Project. [2022]
Using a Veterans Affairs Posttraumatic Stress Disorder Group Therapy Program With Refugees. [2019]
Implementation of a stepped care program to address posttraumatic stress disorder and depression in a Level II trauma center. [2023]
Factors influencing participation in psychosocial programming among orthopaedic trauma patients with PTSD. [2022]
Trauma Resilience and Recovery Program: Addressing Mental Health in Pediatric Trauma Centers. [2022]
The Trauma Resiliency Model: A "Bottom-Up" Intervention for Trauma Psychotherapy. [2019]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security